Oscar Health, Inc. (OSCR)
NYSE: OSCR · IEX Real-Time Price · USD
22.52
+0.37 (1.67%)
At close: May 17, 2024, 4:00 PM
22.49
-0.03 (-0.13%)
After-hours: May 17, 2024, 7:33 PM EDT
Company Description
Oscar Health, Inc. operates as a health insurance in the United States.
The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care.
It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021.
Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Oscar Health, Inc.
| Country | United States |
| IPO Date | Mar 3, 2021 |
| Industry | Healthcare Plans |
| Sector | Healthcare |
| Employees | 2,400 |
| CEO | Mark Thomas Bertolini |
Contact Details
Address: 75 Varick Street, 5th Floor New York, New York 10013 United States | |
| Phone | (646) 403-3677 |
| Website | hioscar.com |
Stock Details
| Ticker Symbol | OSCR |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $39.00 |
| CIK Code | 0001568651 |
| CUSIP Number | 687793109 |
| ISIN Number | US6877931096 |
| SIC Code | 6324 |
Key Executives
| Name | Position |
|---|---|
| Joshua Kushner | Co-Founder and Vice Chairman |
| Mario Tobias Schlosser | Co-Founder, Chief Technology Officer, President of Technology and Director |
| Richard Scott Blackley CPA | Chief Financial Officer |
| Ranmali Bopitiya | Chief Legal Officer |
| Alessandrea Corinne Quane | Executive Vice President and Chief Insurance Officer |
| Mark Thomas Bertolini | Chief Executive Officer and Director |
| Steven Wolin | Chief Operating Officer |
| Victoria Baltrus | Chief Accounting Officer |
| Chris Potochar | Vice President of Treasury and Investor Relations |
| Rebecca Krouse | Chief People Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 7, 2024 | 10-Q | Quarterly Report |
| May 7, 2024 | 8-K | Current Report |
| Apr 25, 2024 | ARS | Filing |
| Apr 25, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 25, 2024 | DEF 14A | Other definitive proxy statements |
| Mar 7, 2024 | 144 | Filing |
| Mar 7, 2024 | 144 | Filing |
| Mar 4, 2024 | 144 | Filing |
| Mar 4, 2024 | 144 | Filing |
| Mar 4, 2024 | 144 | Filing |